Strategies for treating complications of levodopa therapy: [this symposium was held in Vancouver, British Columbia on September 6 and 9, 1993, during the XV World Congress of Neurology]
Gespeichert in:
| Format: | Tagungsbericht Buch |
|---|---|
| Sprache: | Undetermined |
| Veröffentlicht: |
Cleveland, OH
Advanstar Communications
1994
|
| Schriftenreihe: | Neurology
44,7 : Supplement 6 |
| Schlagworte: | |
| Beschreibung: | Literaturangaben |
| Beschreibung: | 44 S. Ill., graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV009798431 | ||
| 003 | DE-604 | ||
| 005 | 20051108 | ||
| 007 | t | ||
| 008 | 940908s1994 ad|| |||| 10||| und d | ||
| 035 | |a (OCoLC)165092337 | ||
| 035 | |a (DE-599)BVBBV009798431 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | |a und | ||
| 049 | |a DE-19 |a DE-20 |a DE-12 | ||
| 245 | 1 | 0 | |a Strategies for treating complications of levodopa therapy |b [this symposium was held in Vancouver, British Columbia on September 6 and 9, 1993, during the XV World Congress of Neurology] |c William C. Koller ... suppl. ed. |
| 264 | 1 | |a Cleveland, OH |b Advanstar Communications |c 1994 | |
| 300 | |a 44 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Neurology |v 44,7 : Supplement |v 6 | |
| 500 | |a Literaturangaben | ||
| 650 | 0 | 7 | |a Cerebrale Bewegungsstörung |0 (DE-588)4147488-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Kontrollierte Wirkstofffreisetzung |0 (DE-588)4165181-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a L-Dopa |0 (DE-588)4114371-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelnebenwirkung |0 (DE-588)4003134-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Parkinson-Krankheit |0 (DE-588)4044683-9 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1993 |z Vancouver British Columbia |2 gnd-content | |
| 689 | 0 | 0 | |a Parkinson-Krankheit |0 (DE-588)4044683-9 |D s |
| 689 | 0 | 1 | |a L-Dopa |0 (DE-588)4114371-1 |D s |
| 689 | 0 | 2 | |a Kontrollierte Wirkstofffreisetzung |0 (DE-588)4165181-9 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a L-Dopa |0 (DE-588)4114371-1 |D s |
| 689 | 1 | 1 | |a Arzneimittelnebenwirkung |0 (DE-588)4003134-2 |D s |
| 689 | 1 | 2 | |a Cerebrale Bewegungsstörung |0 (DE-588)4147488-0 |D s |
| 689 | 1 | 3 | |a Kontrollierte Wirkstofffreisetzung |0 (DE-588)4165181-9 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Koller, William C. |e Sonstige |4 oth | |
| 711 | 2 | |a World Congress of Neurology |n 15 |d 1993 |c Vancouver, British Columbia |j Sonstige |0 (DE-588)2136960-4 |4 oth | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-006482787 | ||
Datensatz im Suchindex
| _version_ | 1804124147316424704 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV009798431 |
| ctrlnum | (OCoLC)165092337 (DE-599)BVBBV009798431 |
| format | Conference Proceeding Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01996nam a2200457 cb4500</leader><controlfield tag="001">BV009798431</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20051108 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">940908s1994 ad|| |||| 10||| und d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)165092337</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV009798431</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">und</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-20</subfield><subfield code="a">DE-12</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Strategies for treating complications of levodopa therapy</subfield><subfield code="b">[this symposium was held in Vancouver, British Columbia on September 6 and 9, 1993, during the XV World Congress of Neurology]</subfield><subfield code="c">William C. Koller ... suppl. ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cleveland, OH</subfield><subfield code="b">Advanstar Communications</subfield><subfield code="c">1994</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">44 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Neurology</subfield><subfield code="v">44,7 : Supplement</subfield><subfield code="v">6</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturangaben</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Cerebrale Bewegungsstörung</subfield><subfield code="0">(DE-588)4147488-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kontrollierte Wirkstofffreisetzung</subfield><subfield code="0">(DE-588)4165181-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">L-Dopa</subfield><subfield code="0">(DE-588)4114371-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelnebenwirkung</subfield><subfield code="0">(DE-588)4003134-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Parkinson-Krankheit</subfield><subfield code="0">(DE-588)4044683-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1993</subfield><subfield code="z">Vancouver British Columbia</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Parkinson-Krankheit</subfield><subfield code="0">(DE-588)4044683-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">L-Dopa</subfield><subfield code="0">(DE-588)4114371-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Kontrollierte Wirkstofffreisetzung</subfield><subfield code="0">(DE-588)4165181-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">L-Dopa</subfield><subfield code="0">(DE-588)4114371-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Arzneimittelnebenwirkung</subfield><subfield code="0">(DE-588)4003134-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Cerebrale Bewegungsstörung</subfield><subfield code="0">(DE-588)4147488-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="3"><subfield code="a">Kontrollierte Wirkstofffreisetzung</subfield><subfield code="0">(DE-588)4165181-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Koller, William C.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="711" ind1="2" ind2=" "><subfield code="a">World Congress of Neurology</subfield><subfield code="n">15</subfield><subfield code="d">1993</subfield><subfield code="c">Vancouver, British Columbia</subfield><subfield code="j">Sonstige</subfield><subfield code="0">(DE-588)2136960-4</subfield><subfield code="4">oth</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-006482787</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1993 Vancouver British Columbia gnd-content |
| genre_facet | Konferenzschrift 1993 Vancouver British Columbia |
| id | DE-604.BV009798431 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T17:41:02Z |
| institution | BVB |
| institution_GND | (DE-588)2136960-4 |
| language | Undetermined |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-006482787 |
| oclc_num | 165092337 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM DE-20 DE-12 |
| owner_facet | DE-19 DE-BY-UBM DE-20 DE-12 |
| physical | 44 S. Ill., graph. Darst. |
| publishDate | 1994 |
| publishDateSearch | 1994 |
| publishDateSort | 1994 |
| publisher | Advanstar Communications |
| record_format | marc |
| series2 | Neurology |
| spelling | Strategies for treating complications of levodopa therapy [this symposium was held in Vancouver, British Columbia on September 6 and 9, 1993, during the XV World Congress of Neurology] William C. Koller ... suppl. ed. Cleveland, OH Advanstar Communications 1994 44 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Neurology 44,7 : Supplement 6 Literaturangaben Cerebrale Bewegungsstörung (DE-588)4147488-0 gnd rswk-swf Kontrollierte Wirkstofffreisetzung (DE-588)4165181-9 gnd rswk-swf L-Dopa (DE-588)4114371-1 gnd rswk-swf Arzneimittelnebenwirkung (DE-588)4003134-2 gnd rswk-swf Parkinson-Krankheit (DE-588)4044683-9 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1993 Vancouver British Columbia gnd-content Parkinson-Krankheit (DE-588)4044683-9 s L-Dopa (DE-588)4114371-1 s Kontrollierte Wirkstofffreisetzung (DE-588)4165181-9 s DE-604 Arzneimittelnebenwirkung (DE-588)4003134-2 s Cerebrale Bewegungsstörung (DE-588)4147488-0 s Koller, William C. Sonstige oth World Congress of Neurology 15 1993 Vancouver, British Columbia Sonstige (DE-588)2136960-4 oth |
| spellingShingle | Strategies for treating complications of levodopa therapy [this symposium was held in Vancouver, British Columbia on September 6 and 9, 1993, during the XV World Congress of Neurology] Cerebrale Bewegungsstörung (DE-588)4147488-0 gnd Kontrollierte Wirkstofffreisetzung (DE-588)4165181-9 gnd L-Dopa (DE-588)4114371-1 gnd Arzneimittelnebenwirkung (DE-588)4003134-2 gnd Parkinson-Krankheit (DE-588)4044683-9 gnd |
| subject_GND | (DE-588)4147488-0 (DE-588)4165181-9 (DE-588)4114371-1 (DE-588)4003134-2 (DE-588)4044683-9 (DE-588)1071861417 |
| title | Strategies for treating complications of levodopa therapy [this symposium was held in Vancouver, British Columbia on September 6 and 9, 1993, during the XV World Congress of Neurology] |
| title_auth | Strategies for treating complications of levodopa therapy [this symposium was held in Vancouver, British Columbia on September 6 and 9, 1993, during the XV World Congress of Neurology] |
| title_exact_search | Strategies for treating complications of levodopa therapy [this symposium was held in Vancouver, British Columbia on September 6 and 9, 1993, during the XV World Congress of Neurology] |
| title_full | Strategies for treating complications of levodopa therapy [this symposium was held in Vancouver, British Columbia on September 6 and 9, 1993, during the XV World Congress of Neurology] William C. Koller ... suppl. ed. |
| title_fullStr | Strategies for treating complications of levodopa therapy [this symposium was held in Vancouver, British Columbia on September 6 and 9, 1993, during the XV World Congress of Neurology] William C. Koller ... suppl. ed. |
| title_full_unstemmed | Strategies for treating complications of levodopa therapy [this symposium was held in Vancouver, British Columbia on September 6 and 9, 1993, during the XV World Congress of Neurology] William C. Koller ... suppl. ed. |
| title_short | Strategies for treating complications of levodopa therapy |
| title_sort | strategies for treating complications of levodopa therapy this symposium was held in vancouver british columbia on september 6 and 9 1993 during the xv world congress of neurology |
| title_sub | [this symposium was held in Vancouver, British Columbia on September 6 and 9, 1993, during the XV World Congress of Neurology] |
| topic | Cerebrale Bewegungsstörung (DE-588)4147488-0 gnd Kontrollierte Wirkstofffreisetzung (DE-588)4165181-9 gnd L-Dopa (DE-588)4114371-1 gnd Arzneimittelnebenwirkung (DE-588)4003134-2 gnd Parkinson-Krankheit (DE-588)4044683-9 gnd |
| topic_facet | Cerebrale Bewegungsstörung Kontrollierte Wirkstofffreisetzung L-Dopa Arzneimittelnebenwirkung Parkinson-Krankheit Konferenzschrift 1993 Vancouver British Columbia |
| work_keys_str_mv | AT kollerwilliamc strategiesfortreatingcomplicationsoflevodopatherapythissymposiumwasheldinvancouverbritishcolumbiaonseptember6and91993duringthexvworldcongressofneurology AT worldcongressofneurologyvancouverbritishcolumbia strategiesfortreatingcomplicationsoflevodopatherapythissymposiumwasheldinvancouverbritishcolumbiaonseptember6and91993duringthexvworldcongressofneurology |